Sale!

GRN Gene Ceroid lipofuscinosis neuronal type 11 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GRN Gene Ceroid Lipofuscinosis Neuronal Type 11 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GRN gene, which are implicated in the development of Ceroid Lipofuscinosis Neuronal type 11 (CLN11), a rare genetic disorder. This condition is part of a group of neurodegenerative diseases known as neuronal ceroid lipofuscinoses (NCLs) that primarily affect the nervous system, leading to a progressive loss of motor skills, seizures, and decline in cognitive function. The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect any genetic anomalies in the GRN gene that could indicate a predisposition to CLN11. By providing a precise genetic diagnosis, this test enables targeted interventions and management strategies, potentially improving the quality of life for individuals with this challenging condition. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes for patients and their families seeking answers to complex genetic questions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GRN Gene Ceroid lipofuscinosis neuronal type 11 Genetic Test

At DNA Labs UAE, we offer the GRN Gene Ceroid lipofuscinosis neuronal type 11 Genetic Test at a cost of AED 4400.0.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the GRN Gene Ceroid lipofuscinosis neuronal type 11 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 11.

Test Details

The GRN gene, also known as progranulin gene, is associated with a neurodegenerative disorder called neuronal ceroid lipofuscinosis type 11 (NCL11). This disorder is characterized by the accumulation of lipofuscin, a fatty pigment, in neurons throughout the body.

NCL11 typically presents in early adulthood with symptoms such as progressive cognitive decline, behavioral changes, seizures, and movement disorders.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of NCL11, NGS genetic testing can be performed to identify mutations or variants in the GRN gene.

This test can help confirm a diagnosis of NCL11 and provide important information for genetic counseling and family planning.

NGS genetic testing involves sequencing the DNA of an individual to identify any genetic changes in the GRN gene. The test can detect small mutations, deletions, insertions, or other genetic alterations that may be responsible for NCL11.

By analyzing the entire coding region of the GRN gene, NGS testing provides comprehensive coverage and higher accuracy compared to traditional sequencing methods.

It’s important to note that NGS genetic testing is typically recommended for individuals who have symptoms consistent with NCL11 or a family history of the condition. A healthcare professional, such as a genetic counselor or neurologist, can guide patients and their families through the testing process and help interpret the results.

Test Name GRN Gene Ceroid lipofuscinosis neuronal type 11 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GRN Gene Ceroid lipofuscinosis neuronal type 11 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 11
Test Details

The GRN gene, also known as progranulin gene, is associated with a neurodegenerative disorder called neuronal ceroid lipofuscinosis type 11 (NCL11). This disorder is characterized by the accumulation of lipofuscin, a fatty pigment, in neurons throughout the body. NCL11 typically presents in early adulthood with symptoms such as progressive cognitive decline, behavioral changes, seizures, and movement disorders.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of NCL11, NGS genetic testing can be performed to identify mutations or variants in the GRN gene. This test can help confirm a diagnosis of NCL11 and provide important information for genetic counseling and family planning.

NGS genetic testing involves sequencing the DNA of an individual to identify any genetic changes in the GRN gene. The test can detect small mutations, deletions, insertions, or other genetic alterations that may be responsible for NCL11. By analyzing the entire coding region of the GRN gene, NGS testing provides comprehensive coverage and higher accuracy compared to traditional sequencing methods.

It’s important to note that NGS genetic testing is typically recommended for individuals who have symptoms consistent with NCL11 or a family history of the condition. A healthcare professional, such as a genetic counselor or neurologist, can guide patients and their families through the testing process and help interpret the results.